Pay for performance (P4P) models have become more popular in reimbursement for medical services, including treatment for substance use disorders. However, studies have not examined whether P4P has an impact on treatment outcome in the individual in opioid agonist treatment (OAT). Thus, the present study was conducted at the individual level, rather than the programmatic level, to determine whether meeting the P4P early engagement criteria (four services in the initial 14 days of treatment and/or eight services within the initial 30 days of treatment) resulted in reduced opioid, benzodiazepine, and cocaine use.

中文翻译：

---

为阿片类药物使用障碍的激动剂治疗支付性能和治疗结果

绩效付费（P4P）模式在医疗服务报销（包括药物滥用疾病的治疗）中越来越流行。但是，研究尚未检查P4P是否对阿片类激动剂治疗（OAT）的个体治疗结果产生影响。因此，本研究是在个人级别而不是在计划级别上进行的，以确定是否满足P4P早期参与标准（在治疗的最初14天提供4个服务和/或在治疗的最初30天提供8个服务）导致阿片类药物，苯二氮卓和可卡因的使用减少。